Aligos Therapeutics, Inc.
ALGS
$10.17
$0.303.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.54M | -15.86M | 43.09M | -82.15M | -19.26M |
| Total Depreciation and Amortization | 220.00K | 259.00K | 194.00K | 671.00K | 248.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.44M | -830.00K | -60.36M | 63.47M | 2.09M |
| Change in Net Operating Assets | 1.53M | 930.00K | -3.84M | -390.00K | -3.18M |
| Cash from Operations | -24.35M | -15.50M | -20.91M | -18.40M | -20.10M |
| Capital Expenditure | -193.00K | -109.00K | -43.00K | -28.00K | -26.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.88M | -39.31M | -44.02M | 20.00M | 10.42M |
| Cash from Investing | 47.68M | -39.42M | -44.07M | 19.97M | 10.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00K | -1.00K | -- | -43.00K | -5.00K |
| Issuance of Common Stock | -- | -- | 101.74M | 140.00K | 1.00K |
| Repurchase of Common Stock | -43.00K | -176.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -53.00K | -177.00K | 101.74M | 97.00K | -4.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.29M | -55.10M | 36.77M | 1.67M | -9.71M |